Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease | Zendy

Valter Donadon | Zendy; Massimiliano Balbi | Zendy; Michela Ghersetti | Zendy; Silvia Grazioli | Zendy; Antonio Perciaccante | Zendy; Giovanni Della Valentina | Zendy; Rita Gardenal | Zendy; Maria Dal Mas | Zendy; Pietro Casarin | Zendy; Giorgio Zanette | Zendy; Cesare Miranda | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease

Author(s) -

Valter Donadon,

Massimiliano Balbi,

Michela Ghersetti,

Silvia Grazioli,

Antonio Perciaccante,

Giovanni Della Valentina,

Rita Gardenal,

Maria Dal Mas,

Pietro Casarin,

Giorgio Zanette,

Cesare Miranda

Publication year - 2009

Publication title -

world journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.427

H-Index - 155

eISSN - 2219-2840

pISSN - 1007-9327

DOI - 10.3748/wjg.15.2506

Subject(s) - medicine , metformin , diabetes mellitus , hepatocellular carcinoma , gastroenterology , cirrhosis , type 2 diabetes mellitus , odds ratio , univariate analysis , insulin , multivariate analysis , endocrinology

To explore the association between hepatocellular carcinoma (HCC) and type 2 diabetes mellitus, describe the temporal relations between the onset of diabetes and the development of HCC and evaluate the possible effects of antidiabetic therapy on HCC risk.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research